Stellar Biotechnologies Welcomes Malcolm Gefter, Ph. D. to Corporate and Scientific Advisory Boards
12 juil. 2010 08h50 HE
|
Stellar Biotechnologies, Inc.
PT. HUENEME, CA--(Marketwire - July 12, 2010) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) (www.stellarbiotechnologies.com) is pleased to announce that eminent biochemist,...
Stellar Biotechnologies Appoints John S. Sundsmo, Ph.D. to VP, Research & IP Management and Daniel C. Adelman, M.D. as Member of SAB
29 juin 2010 09h15 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - June 29, 2010) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed John S. Sundsmo, Ph.D., VP - Research & Intellectual Property...
Stellar Biotechnologies Anuncia Novo Website -- www.StellarBiotechnologies.com
22 juin 2010 20h09 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - June 22, 2010) -
A Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) tem o prazer de anunciar que lançou um novo website dedicado aos seus clientes...
Stellar Biotechnologies anuncia nuevo portal www.StellarBiotechnologies.com
22 juin 2010 20h09 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CALIFORNIA--(Marketwire - June 22, 2010) -
Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) se complace en anunciar el lanzamiento de su nuevo portal diseñado para...
Stellar Biotechnologies Announces New Website -- www.StellarBiotechnologies.com
22 juin 2010 07h45 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - June 22, 2010) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) is pleased to announce that it has released its new customer and investor-friendly...
Stellar Biotechnologies Beginning Preclinical Testing
10 juin 2010 08h45 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - June 10, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) will initiate preclinical testing of its immunogenic agent, Stellar KLH/NeoA,...
Stellar Biotechnologies' Customer -- More Indications for KLH Use
02 juin 2010 07h30 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - June 2, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) ("Stellar") is pleased to announce that its long-term customer, Neovacs SA - Paris (Paris Alternext: ALNEV),...
Stellar Biotechnologies Appoints Andrew Saxon, M.D., Chairman - Scientific Advisory Board (SAB)
12 mai 2010 11h30 HE
|
Stellar Biotechnologies, Inc.
VANCOUVER, BC--(Marketwire - May 12, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) has appointed Dr. Andrew Saxon, a world-renowned expert in human cellular and molecular immunology, Andrew...
Stellar Biotechnologies Appoints Daniel E. Morse, Ph. D., Director and VP
29 avr. 2010 08h45 HE
|
Stellar Biotechnologies, Inc.
VANCOUVER, BC--(Marketwire - April 29, 2010) - Stellar Biotechnologies, Inc. (TSX-V: KLH) has appointed eminent scientist Daniel E. Morse, Ph. D. as Director and Executive VP: Science &...
Stellar Biotechnologies Now Public
20 avr. 2010 08h30 HE
|
Stellar Biotechnologies, Inc.
VANCOUVER, BC--(Marketwire - April 20, 2010) - CAG Capital (now Stellar Biotechnologies, Inc.) (TSX-V: KLH) announces acquisition of Stellar Biotechnologies --...